Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 4533-4540, December 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pleshkewych, A.
Right arrow Articles by Porter, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pleshkewych, A.
Right arrow Articles by Porter, C. W.

Independence of Drug Action on Mitochondria and Polyamines in L1210 Leukemia Cells Treated with Methylglyoxal-bis(guanylhydrazone)1

A. Pleshkewych, D. L. Kramer, E. Kelly and Carl W. Porter2

Department of Natural Sciences, Daemen College, Amherst, New York 14226 [A. P.], and Department of Experimental Therapeutics, Grace Cancer Drug Center, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, New York 14263 [D. L. K., E. K., C. W. P.]

The relationship between inhibition of polyamine biosynthesis and interference with mitochondrial structure and function by the antitumor agent, methylglyoxal-bis(guanylhydrazone) (MGBG), was examined by studying the temporal sequence of events relevant to these two drug actions. In ascites L1210 cells treated in vivo with a single dose of MGBG (75 mg/kg), significant inhibition of pyruvate utilization, used here as a measure of mitochondrial function, occurred within 1 hr after initiation of drug treatment and continued to decrease for 24 hr. Ultrastructural damage to mitochondria, in the form of swelling, was first apparent in 50% of the cells after 6 hr of treatment and in > 90% of the cells after 20 hr. Inhibition of S-adenosylmethionine decarboxylase, a key enzyme in spermidine and spermine biosynthesis, occurred within 1 hr of drug treatment. Enzyme levels increased dramatically after 8 hr of treatment as a result of MGBG stabilization of the enzyme. Beginning at 8 hr, ornithine decarboxylase, the enzyme responsible for putrescine synthesis, increased slightly and continued to rise slowly during the next 16 hr. As a consequence of S-adenosylmethionine decarboxylase inhibition by MGBG, intracellular putrescine pools began to accumulate after 2 hr of treatment and increased rapidly after 12 hr. In contrast, spermine pools decreased slowly after 4 hr while spermidine pools decreased even more slowly. However, even after 24 hr, significant amounts of both polyamines were still present intracellularly.

Since MGBG-induced changes in mitochondrial function precede significant alterations in polyamine pools, it is concluded that the two effects are separable. This conclusion is further supported by the finding that, in cultured L1210 cells treated with {alpha}-methylornithine at concentrations which effectively inhibited putrescine and spermidine biosynthesis, the mitochondrial ultrastructure was unaffected. Results of the present study raise the possibility that MGBG interference with mitochondrial function might be responsible for the early antiproliferative action of the drug.

1 This investigation was supported by Research Grants CA-22153 and CA-24538 from the National Cancer Institute, Department of Health, Education and Welfare.

2 To whom requests for reprints should be addressed.

Received 5/19/80. Accepted 9/ 8/80.




This article has been cited by other articles:


Home page
ScienceHome page
C. Porter and R. Bergeron
Spermidine requirement for cell proliferation in eukaryotic cells: structural specificity and quantitation
Science, March 4, 1983; 219(4588): 1083 - 1085.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.